Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06177990 · ClinicalTrials.gov registry record · NA
Caregiver as Navigator: Develop Skills Online (CAN-DO)
A NA study of Dementia, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT06177990: Recruiting NA study of Dementia, sponsored by Emory University.
NCT06177990 is a NA study of Dementia that is actively recruiting participants, run by Emory University. The registered enrollment target is 270 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06177990, a NA study of Dementia, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to learn more about ways to promote caregiver mastery online. 270 dementia family caregivers will be enrolled and randomized to take the CAN-DO online course immediately or after a waiting period. They will participate in interviews before and after the course; total time of study participation is 6 months.
Primary Outcome
This primary outcome will measure Caregiver Mastery (including Competence, Confidence, Management of Situation). The Pearlin caregiver scale includes 8 items, with a rating from 1-4 for each of them. Total possible score range is 8-32. Higher score correlates with better outcome.
Conditions Studied
Interventions
- OTHER Caregiver as Navigator: Develop Skills Online (CAN-DO) program
- OTHER Healthy Living online course
Study Locations (1)
Georgia
- Emory Roybal Center for Dementia Caregiving Mastery - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2024-12-26 |
| Est. Completion | 2028-03 |
| Phase | NA |
What NCT06177990 shows while recruiting
NCT06177990 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Caregiver as Navigator: Develop Skills Online (CAN-DO) program is the first listed.
NCT06177990 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06177990 about?
NCT06177990 is a clinical study titled "Caregiver as Navigator: Develop Skills Online (CAN-DO)". This study is designed to learn more about ways to promote caregiver mastery online. 270 dementia family caregivers will be enrolled and randomized to take the CAN-DO online course immediately or after a waiting period. They will participate in interviews before and after the course; total time of s...
What is the current status of trial NCT06177990?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2024-12-26. Estimated completion is 2028-03.
What conditions does trial NCT06177990 study?
This clinical trial studies the following conditions: Dementia.
What interventions are being tested in trial NCT06177990?
The interventions under investigation include: Caregiver as Navigator: Develop Skills Online (CAN-DO) program (OTHER), Healthy Living online course (OTHER).
Who is sponsoring clinical trial NCT06177990?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06177990 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06177990's enrollment target sits among peer trials
270 77th of 199 higher than 122 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
-
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI